A. Mendes-Pereira
Molecular Biology · 2009
A researcher in the Science corpus: 1 paper; trusts 3 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 12 citations into it
- Oncology — 8 citations into it
Whom A. Mendes-Pereira trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from A. Mendes-Pereira's perspective
Ordered by how strongly the researchers A. Mendes-Pereira trusts endorse each paper. Same corpus, a different order for every researcher.
- A synthetic lethal therapeutic approach: poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair. (Journal of Clinical Oncology)
- Tenets of PTEN tumor suppression. (Cell)
- Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy (Nature)
- Ubiquitination regulates PTEN nuclear import and tumor suppression. (Cell)
- The Concept of Synthetic Lethality in the Context of Anticancer Therapy (Nature Reviews. Cancer)
- Molecular views of recombination proteins and their control (Nature reviews. Molecular cell biology)
- Resistance to therapy caused by intragenic deletion in BRCA2 (Nature)
- Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. (New England Journal of Medicine)
- Essential role for nuclear PTEN in maintaining chromosomal integrity. (Cell)
- BRCA2 is required for homology-directed repair of chromosomal breaks. (Molecules and Cells)
Their papers
- Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors (2009) — 674 citations